Filter Results:
(911)
Show Results For
- All HBS Web
(1,818)
- People (5)
- News (461)
- Research (911)
- Events (8)
- Multimedia (12)
- Faculty Publications (469)
Show Results For
- All HBS Web
(1,818)
- People (5)
- News (461)
- Research (911)
- Events (8)
- Multimedia (12)
- Faculty Publications (469)
Sort by
- 16 Aug 2024
- In Practice
Election 2024: What's at Stake for Business and the Workplace?
vital infrastructure that keeps the economy—and goods and services—moving, including roads, bridges, ports, and freight trains. Businesses that want employees to return to the office know that commute times can depend on potholes and View Details
Keywords: by Rachel Layne
- 09 May 2017
- First Look
New Research and Ideas, May 9
sudden rise of new entrants, especially Germany. The study shows that natural resource endowment is a poor explanatory variable for this geographical skewing. Public policy was a more important factor, although its impact was nuanced. The... View Details
Keywords: Sean Silverthorne
- 18 Oct 2010
- Lessons from the Classroom
Venture Capital’s Disconnect with Clean Tech
MBA students often fall into one of two categories—those hungry to rush into careers as venture capitalists, and those eager to found a venture-funded start-up. For all of them, Harvard Business School professor Joseph Lassiter has some intriguing advice: Spend a few... View Details
- November 2001 (Revised September 2004)
- Case
Evolution of Treatment, The: The Case of Diabetes
By: Richard M.J. Bohmer, Jeffrey D. Street and Laura Feldman
Scientific knowledge surrounding diabetes mellitus has grown over the last century to include its cause, treatment, and prevention strategies. However, the type and level of care that patients receive is suboptional. This case examines the forces in industry,... View Details
Keywords: Policy; Health Care and Treatment; Innovation and Management; Knowledge Use and Leverage; Management; Management Analysis, Tools, and Techniques; Health Industry
Bohmer, Richard M.J., Jeffrey D. Street, and Laura Feldman. "Evolution of Treatment, The: The Case of Diabetes." Harvard Business School Case 302-023, November 2001. (Revised September 2004.)
- 14 Jan 2008
- Research & Ideas
Mapping Polluters, Encouraging Protectors
its infancy, Toffel concurs. From a public health perspective, it would be quite useful to map, for instance, how individuals are exposed to pollutants based on where they live: Living upwind or downwind... View Details
- 2024
- Working Paper
Why Most Resist AI Companions
By: Julian De Freitas, Zeliha Oğuz-Uğuralp, Ahmet Kaan Uğuralp and Stefano Puntoni
Chatbots are now able to form emotional relationships with people and alleviate loneliness—a growing public health concern. Behavioral research provides little insight into whether everyday people are likely to use these applications and why. We address this question... View Details
Keywords: Generative Ai; Chatbots; Artificial Intelligence; Algorithmic Aversion; Lonelines; Technology Adoption; AI and Machine Learning; Well-being; Emotions
De Freitas, Julian, Zeliha Oğuz-Uğuralp, Ahmet Kaan Uğuralp, and Stefano Puntoni. "Why Most Resist AI Companions." Harvard Business School Working Paper, No. 25-030, December 2024. (Revised January 2025.)
- 16 Dec 2014
- First Look
First Look: December 16
Publications December 2014 Management Science When Performance Trumps Gender Bias: Joint Versus Separate Evaluation By: Bohnet, Iris, Alexandra van Geen, and Max Bazerman Abstract—We examine a new intervention to overcome gender biases in... View Details
Keywords: Sean Silverthorne
- March 2021 (Revised January 2023)
- Case
The Trouble with TCE
By: Vincent Pons, Rafael Di Tella and Galit Goldstein
Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other... View Details
Keywords: Trichloroethylene; Toxicity; Lobbying; Chemicals; Health Disorders; Governing Rules, Regulations, and Reforms; Policy; Ethics; Business and Government Relations; Chemical Industry; United States
Pons, Vincent, Rafael Di Tella, and Galit Goldstein. "The Trouble with TCE." Harvard Business School Case 721-031, March 2021. (Revised January 2023.)
- March 2012
- Article
Fixing What's Wrong with U. S. Politics
By: David A. Moss
In America today there's a growing sense that the political system is broken and that its ineffectiveness is a major threat to U.S. competitiveness. Why do so many think the political system is not working? Research shows that in Congress, Republicans and Democrats are... View Details
Keywords: Government and Politics; System; Conflict Management; Performance Productivity; Policy; Public Administration Industry; United States
Moss, David A. "Fixing What's Wrong with U. S. Politics." Harvard Business Review 90, no. 3 (March 2012).
- July–August 2018
- Article
When Technology Gets Ahead of Society
By: Tarun Khanna
New technologies can be unsettling for industry incumbents, regulators, and consumers, because norms and institutions for dealing with them don’t yet exist. Interestingly, businesspeople in emerging economies face similar challenges: The rules are unclear and... View Details
Keywords: Technological Innovation; Society; Situation or Environment; Infrastructure; Entrepreneurship; Performance Effectiveness; Cooperation
Khanna, Tarun. "When Technology Gets Ahead of Society." Harvard Business Review 96, no. 4 (July–August 2018): 86–95.
- 21 Jan 2010
- Working Paper Summaries
Going Through the Motions: An Empirical Test of Management Involvement in Process Improvement
- June 2023
- Case
Verve Therapeutics: Taking DNA Editing to Heart
By: Shikhar Ghosh and Shweta Bagai
Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details
Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry
Ghosh, Shikhar, and Shweta Bagai. "Verve Therapeutics: Taking DNA Editing to Heart." Harvard Business School Case 823-113, June 2023.
- April 1991 (Revised April 1992)
- Case
Hospital Sector in 1992
Examines the major issues facing the hospital sector in 1992. The environment surrounding the industry is one of great uncertainty and rapid change, and involves significant public policy questions. Describes recent trends, issues and new types of competitors that... View Details
Keywords: Risk and Uncertainty; Nonprofit Organizations; Competition; Health Care and Treatment; Policy; Change; Health Industry; United States
Teisberg, Elizabeth O. "Hospital Sector in 1992." Harvard Business School Case 391-167, April 1991. (Revised April 1992.)
- March 2023
- Case
Roche: ESG and Access to Healthcare
By: George Serafeim, Susanna Gallani and Benjamin Maletta
In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first ESG investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that... View Details
Keywords: ESG (Environmental, Social, Governance) Performance; Sustainable Finance; Growth Strategy And Execution; Sustainability Targets; Impact Evaluation; Healthcare Access; Healthcare Innovation; Healthcare Systems; Healthcare Operations; Finance; Strategy; Health Testing and Trials; Health Care and Treatment; Growth Management; Measurement and Metrics; Innovation Strategy; Corporate Social Responsibility and Impact; Health Industry; Health Industry; Switzerland; North America; Europe; Asia; Latin America; Africa
Serafeim, George, Susanna Gallani, and Benjamin Maletta. "Roche: ESG and Access to Healthcare." Harvard Business School Case 123-075, March 2023.
- Research Summary
Current Research
By: Leslie K. John
Professor John is a behavioral scientist who uses both laboratory and field experiments to investigate questions that are at the intersection of marketing, organizational behavior, and public policy.
Professor John’s work has been published in leading... View Details
- 02 Jan 2024
- Research & Ideas
10 Trends to Watch in 2024
The lightning-fast ascent of generative AI isn’t the only sea change on the horizon for businesses in the new year. The global economy is in flux as war, climate change, trade issues, and infrastructure problems demand attention. Many companies continue to struggle to... View Details
Keywords: by Rachel Layne
- 05 Jun 2012
- First Look
First Look: June 5
agendas, whose strategies to build viable business models proved crucially dependent on two exogenous factors: the prices of alternative conventional fuels and public policy. Supportive public policies in... View Details
Keywords: Sean Silverthorne
- December 2021
- Case
Pairwise
By: José B. Alvarez and Annelena Lobb
Pairwise discusses the strategic approach of a company aiming to “snackify” fruits and vegetables by using CRISPR-Cas9 gene editing to create nutritious, bite-sized foods that could compete with packaged snacks. The company is confronting a number of challenges,... View Details
Keywords: Gene Editing; GMO; Food; Nutrition; Competition; Market Entry and Exit; Public Opinion; Competitive Strategy; Consumer Behavior; Food and Beverage Industry
Alvarez, José B., and Annelena Lobb. "Pairwise." Harvard Business School Case 522-058, December 2021.
- 20 Jul 2010
- First Look
First Look: July 20
Publications Market Reaction to and Valuation of IFRS Reconciliation Adjustments: First Evidence from the UK Authors: Joanne Horton and George Serafeim Publication: Review of Accounting Studies (forthcoming) Abstract We investigate the... View Details
Keywords: Martha Lagace
- July 2002 (Revised August 2002)
- Case
Washington Hospital Center (D): Emergency Medicine After September 11
By: Rosabeth M. Kanter and Michelle Heskett
The all-risks-ready emergency room prototype project becomes widely accepted as a need after September 11, 2001. The already operational medical informatics system, Insight, comes under heavy demand after its strong performance during crises and is noticed by various... View Details